WTAP is a novel oncogenic protein in acute myeloid leukemia

被引：228
|
作者：
Bansal, H. [1 ]
Yihua, Q. [2 ,3 ]
Iyer, S. P. [4 ]
Ganapathy, S. [1 ]
Proia, D. [5 ]
Penalva, L. O. [1 ,6 ]
Uren, P. J. [7 ]
Suresh, U. [1 ]
Carew, J. S.
Karnad, A. B. [8 ]
Weitman, S. [9 ]
Tomlinson, G. E. [1 ]
Rao, M. K. [1 ,6 ]
Kornblau, S. M. [2 ,3 ]
Bansal, S. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Methodist Canc Ctr, Houston, TX USA
[5] Synta Pharmaceut Corp, Lexington, MA USA
[6] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
[7] Univ So Calif, Div Biol Sci, Los Angeles, CA USA
[8] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[9] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Inst Drug Dev, San Antonio, TX 78229 USA
来源：
LEUKEMIA | 2014年 / 28卷 / 05期
关键词：
TUMOR 1-ASSOCIATING PROTEIN; CANCER; HSP90; TRANSFORMATION; EXPRESSION; THERAPY; BIOLOGY;
D O I：
10.1038/leu.2014.16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1171 / 1174
页数：4
相关论文
共 50 条
  • [41] Repositioning of bromocriptine for treatment of acute myeloid leukemia
    Carmen Lara-Castillo, Maria
    Maria Cornet-Masana, Josep
    Etxabe, Amaia
    Banus-Mulet, Antonia
    Angel Torrente, Miguel
    Nomdedeu, Meritxell
    Diaz-Beya, Marina
    Esteve, Jordi
    Risueno, Ruth M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [42] Antitumoral effect of Ocoxin on acute myeloid leukemia
    Diaz-Rodriguez, Elena
    Hernandez-Garcia, Susana
    Sanz, Eduardo
    Pandiella, Atanasio
    ONCOTARGET, 2016, 7 (05) : 6231 - 6242
  • [43] Evaluating ivosidenib for the treatment of acute myeloid leukemia
    Donker, M. L.
    Ossenkoppele, G. J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (18) : 2205 - 2213
  • [44] Secondary acute myeloid leukemia occurring after successful treatment of acute promyelocytic leukemia
    Chen, Junfa
    Zheng, Zhiyin
    Shen, Jianping
    Peng, Leijun
    Zhuang, Haifeng
    Liu, Wenbin
    Zhou, Yuhong
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (03) : 327 - 328
  • [45] The clinical significance of γ-catenin in acute myeloid leukemia
    Xu, Jiadai
    Wu, Wei
    Shen, Wenyi
    Liu, Peng
    ONCOTARGETS AND THERAPY, 2016, 9 : 3861 - 3871
  • [46] The increasing genomic complexity of acute myeloid leukemia
    Rowe, Jacob M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (3-4) : 209 - 213
  • [47] Numb Chin Syndrome in Acute Myeloid Leukemia
    Jenkins, Russell W.
    McDonald, Kristine
    Greenberg, Charles S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (03) : 237 - 240
  • [48] CD33 directed bispecific antibodies in acute myeloid leukemia
    Clark, Mary C.
    Stein, Anthony
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [49] Acute Myeloid Leukemia with Myelodysplasia-related Changes Mimicking Acute Promyelocytic Leukemia
    Machida, Hisanori
    Shinohara, Tsutomu
    Iwahara, Yoshihito
    Hatakeyama, Nobuo
    Okano, Yoshio
    Nakano, Mayuri
    Hosokawa, Emiko
    Abe, Shuichi
    Naruse, Keishi
    Ogushi, Fumitaka
    INTERNAL MEDICINE, 2011, 50 (24) : 3037 - 3041
  • [50] The role of autophagy in acute myeloid leukemia development
    Bednarczyk, Martyna
    Kociszewska, Karolina
    Grosicka, Olga
    Grosicki, Sebastian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (01) : 5 - 18
12345